Effect of proANF-(31-67) on sodium excretion in conscious monkeys

B. A. Benjamin, T. V. Peterson

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The purpose of this study was to determine the effect of proANF-(31-67) on renal function in conscious, chronically instrumented monkeys (Macaca fascicularis). The experimental protocol consisted of a 30-min control period followed by 60 min of peptide infusion and a 30-min recovery period. Atrial natriuretic factor (ANF)-(99-126), proANF-(31-67), or a combination of ANF- (99-126) plus proANF-(31-67) was infused at 15 pmol · kg-1 · min-1 . ANF-(99-126) caused sodium excretion to increase from 12.5 ± 3 to a peak of 37.9 ± 10.4 μeq/min, whereas fractional sodium excretion (FE(Na)) increased from 0.69 ± 0.2 to 2.3 ± 0.43%. ProANF-(31-67) increased sodium excretion from 12.7 ± 5 to a peak of 23.3 ± 9.0 μeq/min and FE(Na) from 0.56 ± 0.07 to a peak of 1.15 ± 0.4%. When ANF-(99-126) and proANF-(31-67) were infused in combination, sodium excretion increased from 9.6 ± 3 to a peak of 51.9 ± 12.5 μeq/min, whereas FE(Na) increased from 0.97 ± 0.4 to 3.9 ± 1.1%. Mean arterial pressure decreased by ~10 mmHg in all three groups. These findings indicate that intravenously administered pro-ANF-(31-67) causes an increase in sodium excretion and that when proANF-(31-67) and ANF-(99-126) are given in combination, they act in an additive fashion to increase renal sodium excretion.

Original languageEnglish
Pages (from-to)R1351-R1355
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume269
Issue number6 38-6
StatePublished - 1 Dec 1995

Fingerprint

atrial natriuretic peptide
Atrial Natriuretic Factor
Haplorhini
monkeys
excretion
Sodium
sodium
Macaca fascicularis
renal function
atrial natriuretic factor prohormone (31-67)
kidneys
peptides
Arterial Pressure
Kidney
Peptides

Keywords

  • atrial peptides
  • natriuresis
  • prohormone

Cite this

@article{ebef67504ba24419bf16259cc1891dcf,
title = "Effect of proANF-(31-67) on sodium excretion in conscious monkeys",
abstract = "The purpose of this study was to determine the effect of proANF-(31-67) on renal function in conscious, chronically instrumented monkeys (Macaca fascicularis). The experimental protocol consisted of a 30-min control period followed by 60 min of peptide infusion and a 30-min recovery period. Atrial natriuretic factor (ANF)-(99-126), proANF-(31-67), or a combination of ANF- (99-126) plus proANF-(31-67) was infused at 15 pmol · kg-1 · min-1 . ANF-(99-126) caused sodium excretion to increase from 12.5 ± 3 to a peak of 37.9 ± 10.4 μeq/min, whereas fractional sodium excretion (FE(Na)) increased from 0.69 ± 0.2 to 2.3 ± 0.43{\%}. ProANF-(31-67) increased sodium excretion from 12.7 ± 5 to a peak of 23.3 ± 9.0 μeq/min and FE(Na) from 0.56 ± 0.07 to a peak of 1.15 ± 0.4{\%}. When ANF-(99-126) and proANF-(31-67) were infused in combination, sodium excretion increased from 9.6 ± 3 to a peak of 51.9 ± 12.5 μeq/min, whereas FE(Na) increased from 0.97 ± 0.4 to 3.9 ± 1.1{\%}. Mean arterial pressure decreased by ~10 mmHg in all three groups. These findings indicate that intravenously administered pro-ANF-(31-67) causes an increase in sodium excretion and that when proANF-(31-67) and ANF-(99-126) are given in combination, they act in an additive fashion to increase renal sodium excretion.",
keywords = "atrial peptides, natriuresis, prohormone",
author = "Benjamin, {B. A.} and Peterson, {T. V.}",
year = "1995",
month = "12",
day = "1",
language = "English",
volume = "269",
pages = "R1351--R1355",
journal = "American Journal of Physiology - Regulatory Integrative and Comparative Physiology",
issn = "0002-9513",
publisher = "American Physiological Society",
number = "6 38-6",

}

Effect of proANF-(31-67) on sodium excretion in conscious monkeys. / Benjamin, B. A.; Peterson, T. V.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 269, No. 6 38-6, 01.12.1995, p. R1351-R1355.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of proANF-(31-67) on sodium excretion in conscious monkeys

AU - Benjamin, B. A.

AU - Peterson, T. V.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - The purpose of this study was to determine the effect of proANF-(31-67) on renal function in conscious, chronically instrumented monkeys (Macaca fascicularis). The experimental protocol consisted of a 30-min control period followed by 60 min of peptide infusion and a 30-min recovery period. Atrial natriuretic factor (ANF)-(99-126), proANF-(31-67), or a combination of ANF- (99-126) plus proANF-(31-67) was infused at 15 pmol · kg-1 · min-1 . ANF-(99-126) caused sodium excretion to increase from 12.5 ± 3 to a peak of 37.9 ± 10.4 μeq/min, whereas fractional sodium excretion (FE(Na)) increased from 0.69 ± 0.2 to 2.3 ± 0.43%. ProANF-(31-67) increased sodium excretion from 12.7 ± 5 to a peak of 23.3 ± 9.0 μeq/min and FE(Na) from 0.56 ± 0.07 to a peak of 1.15 ± 0.4%. When ANF-(99-126) and proANF-(31-67) were infused in combination, sodium excretion increased from 9.6 ± 3 to a peak of 51.9 ± 12.5 μeq/min, whereas FE(Na) increased from 0.97 ± 0.4 to 3.9 ± 1.1%. Mean arterial pressure decreased by ~10 mmHg in all three groups. These findings indicate that intravenously administered pro-ANF-(31-67) causes an increase in sodium excretion and that when proANF-(31-67) and ANF-(99-126) are given in combination, they act in an additive fashion to increase renal sodium excretion.

AB - The purpose of this study was to determine the effect of proANF-(31-67) on renal function in conscious, chronically instrumented monkeys (Macaca fascicularis). The experimental protocol consisted of a 30-min control period followed by 60 min of peptide infusion and a 30-min recovery period. Atrial natriuretic factor (ANF)-(99-126), proANF-(31-67), or a combination of ANF- (99-126) plus proANF-(31-67) was infused at 15 pmol · kg-1 · min-1 . ANF-(99-126) caused sodium excretion to increase from 12.5 ± 3 to a peak of 37.9 ± 10.4 μeq/min, whereas fractional sodium excretion (FE(Na)) increased from 0.69 ± 0.2 to 2.3 ± 0.43%. ProANF-(31-67) increased sodium excretion from 12.7 ± 5 to a peak of 23.3 ± 9.0 μeq/min and FE(Na) from 0.56 ± 0.07 to a peak of 1.15 ± 0.4%. When ANF-(99-126) and proANF-(31-67) were infused in combination, sodium excretion increased from 9.6 ± 3 to a peak of 51.9 ± 12.5 μeq/min, whereas FE(Na) increased from 0.97 ± 0.4 to 3.9 ± 1.1%. Mean arterial pressure decreased by ~10 mmHg in all three groups. These findings indicate that intravenously administered pro-ANF-(31-67) causes an increase in sodium excretion and that when proANF-(31-67) and ANF-(99-126) are given in combination, they act in an additive fashion to increase renal sodium excretion.

KW - atrial peptides

KW - natriuresis

KW - prohormone

UR - http://www.scopus.com/inward/record.url?scp=0029201690&partnerID=8YFLogxK

M3 - Article

C2 - 8594937

AN - SCOPUS:0029201690

VL - 269

SP - R1351-R1355

JO - American Journal of Physiology - Regulatory Integrative and Comparative Physiology

JF - American Journal of Physiology - Regulatory Integrative and Comparative Physiology

SN - 0002-9513

IS - 6 38-6

ER -